FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Drug Relief v1
K Number: K221231
·
Decision Jun 6, 2022
Classifications
1
FEI Numbers
6
Registration Numbers
6
Same Product Code
7
Applicant Total
14
Review Days
38
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Drug Relief v1
- K Number
- K221231
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 882.5896
- Medical Specialty
- Neurology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Dyansys, Inc.
- Date Received
- April 29, 2022
- Decision Date
- June 6, 2022
- Product Code
- PZR
- Advisory Committee
- Neurology
- Review Advisory Committee
- NE
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PZR | Percutaneous Nerve Stimulator For Opioid Withdrawal | FDA class 2 | Neurology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (PZR), ordered by most recent decision date.
Sparrow Ascent
FDA 510(k)
FDA Class 2
·Neurology
NET Recovery Corp/NET Device
FDA 510(k)
FDA Class 2
·Neurology
Sparrow Ascent
FDA 510(k)
FDA Class 2
·Neurology
Drug Relief v1
FDA 510(k)
FDA Class 2
·Neurology
Sparrow Therapy System
FDA 510(k)
FDA Class 2
·Neurology
Drug Relief
FDA 510(k)
FDA Class 2
·Neurology
Other Clearances by Dyansys, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K221425 | Primary Relief | Sep 13, 2022 | Substantially Equivalent |
| K220397 | ANSiStim-PP | May 12, 2022 | Substantially Equivalent |
| K213188 | Primary Relief | Jan 31, 2022 | Substantially Equivalent |
| K212859 | First Relief | Dec 20, 2021 | Substantially Equivalent |
| K211971 | Drug Relief v1 | Nov 5, 2021 | Substantially Equivalent |
| K202940 | First Relief v1 | Dec 29, 2020 | Substantially Equivalent |
| K173861 | Drug Relief | May 2, 2018 | Substantially Equivalent |
| K170391 | ANSiStim-PP | Mar 9, 2017 | Substantially Equivalent |
| K141168 | ANSISTIM | May 15, 2015 | Substantially Equivalent |
| K091397 | ECSCOPE 200 | Jul 8, 2009 | Substantially Equivalent |